Latest News and Press Releases

Kraig Biocraft Laboratories (OTCQB:KBLB) is attracting additional attention, as its spider silk technology is featured on the cover of National Geographic

Kraig Biocraft Labs (OTCQB: KBLB) groundbreaking work in commercializing spider silk is featured on the cover of the March 2026 issue of National Graphic

U.S. equity markets are pointing modestly lower this morning and any fresh Fed commentary, but today’s headlines are dominated by transformative stocks

Dublin, Feb. 19, 2026 (GLOBE NEWSWIRE) -- The "Cell and Gene Therapy Tools and Reagents: Global Markets" has been added to ResearchAndMarkets.com's offering.The global market for cell and gene...

Kraig Labs (OTCQB: KBLB) is entering its defining phase and accelerating toward commercial-scale production of biodegradable spider silk

Execution is the theme this morning, as a cluster of emerging growth stocks move from pilot programs and strategic roadmaps into operational scale.

Kraig Biocraft Laboratories (OTCQB: KBLB) announced that its 2026 production plan has officially moved from strategy to execution.

Kraig Labs (OTCQB: KBLB) is entering a new phase of commercial scale-up as it accelerates spider silk production to meet growing demand from global brands.

Clinical data disclosed in November 2025 to be presented at medical meeting with new supportive translational data for both programs Vispa-cel (CB-010) ANTLER phase 1 translational and clinical data...

Dublin, Jan. 28, 2026 (GLOBE NEWSWIRE) -- The "Gene Therapy Market" has been added to ResearchAndMarkets.com's offering. The gene therapy market is forecasted to expand significantly, with a...